- Country: Sri Lanka
- Summary: Silver Sulphadiazine Cream Usp/ip 1%, W/w 500g Jar Silver Sulphadiazine Cream Usp/ip 1%, W/w 500g Each 500g Jar To Contain 1% W/w Of Silver Sulphadiazine Usp/ip In An Suitable Cream Base.
- LKT Ref No: 110728509
- Deadline: 07 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: DHS/P/WW/431/25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Silver Sulphadiazine Cream Usp/ip 1%, W/w 500g Jar Silver Sulphadiazine Cream Usp/ip 1%, W/w 500g Each 500g Jar To Contain 1% W/w Of Silver Sulphadiazine Usp/ip In An Suitable Cream Base.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSilver Sulphadiazine Cream Usp/ip 1%, W/w 500g Jar Silver Sulphadiazine Cream Usp/ip 1%, W/w 500g Each 500g Jar To Contain 1% W/w Of Silver Sulphadiazine Usp/ip In An Suitable Cream Base. - Srilanka Tender
The STATE PHARMACEUTICALS CORPORATION OF SRI LANKA, a Government sector organization in Sri Lanka, has announced a new tender for Silver Sulphadiazine Cream Usp/ip 1%, W/w 500g Jar Silver Sulphadiazine Cream Usp/ip 1%, W/w 500g Each 500g Jar To Contain 1% W/w Of Silver Sulphadiazine Usp/ip In An Suitable Cream Base.. This tender is published on SrilankaTender under LKT Ref No: 110728509 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
